MitraClip® therapy in patients with end-stage systolic heart failure.
Related Research units
Abstract
To assess the feasibility, short-term durability and clinical outcomes of MitraClip® therapy for mitral regurgitation (MR) in patients with end-stage heart failure and a severely reduced left ventricular (LV) ejection fraction.
Bibliographical data
| Original language | English |
|---|---|
| Article number | 5 |
| ISSN | 1388-9842 |
| Publication status | Published - 2011 |
| pubmed | 21471146 |
|---|
